XML 25 R16.htm IDEA: XBRL DOCUMENT

10. Capital Transactions	9 Months Ended
Sep. 30, 2016
Notes to Financial Statements
9. Capital Transactions	On January 22, 2008, the Board of Directors of the Company authorized a buy back of up to 300,000 shares of common stock. Shares will be purchased from time to time, at management’s discretion, in the open market and in private transactions. The Company did not purchase any shares during the three and nine months ended September 30, 2016. Other than the expiration of options referred to below, there were no stock option transactions during the nine months ended September 30, 2016. At September 30, 2016, there were 240,000 outstanding options at a weighted average exercise price of $3.05, all of which were fully vested and exercisable. There were 25,000 options at a weighted average exercise price of $2.75 that expired in the third quarter ended September 30, 2016. As of September 30, 2016, there were no unrecognized compensation costs.

10. Capital Transactions

9 Months Ended

Sep. 30, 2016

On January 22, 2008, the Board of Directors of the Company authorized a buy back of up to 300,000 shares of common stock. Shares will be purchased from time to time, at management’s discretion, in the open market and in private transactions. The Company did not purchase any shares during the three and nine months ended September 30, 2016.

Other than the expiration of options referred to below, there were no stock option transactions during the nine months ended September 30, 2016. At September 30, 2016, there were 240,000 outstanding options at a weighted average exercise price of $3.05, all of which were fully vested and exercisable. There were 25,000 options at a weighted average exercise price of $2.75 that expired in the third quarter ended September 30, 2016. As of September 30, 2016, there were no unrecognized compensation costs.